Peritoneal Mesothelial Neoplasm — Trials

Peritoneal Mesothelial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

27 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07277413	A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors	recruiting	Phase 1	260	IDEAYA BiosciencesINDUSTRY	1	Sep 28, 2026	clinicaltrials
NCT04847063	Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies	recruiting	Phase 1	60	National Cancer Institute (NCI)NIH	1	Aug 25, 2026	clinicaltrials
NCT02535312	Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin	active not recruiting	Phase 1 / Phase 2	30	National Cancer Institute (NCI)NIH	1	Jul 31, 2026	clinicaltrials

Data updated 2 days agoSource updated Sep 28, 2026source: clinicaltrials